The need for Stroke code and Thrombectomy in Pakistan

Authors

  • Hassan Tanvir Ramzi Department of Medicine, Ibne Siena Hospital and Research Institute, Multan, Pakistan
  • Mohammad Shehryar Khurram Department of Neurosurgery, Ibne Siena Hospital and Research Institute, Multan, Pakistan
  • Sana Manzoor Department of Medicine, Ibne Siena Hospital and Research Institute, Multan, Pakistan

DOI:

https://doi.org/10.47391/JPMA.7037

Abstract

Stroke is one of the oldest studied medical illnesses, but it remains the second leading cause of mortality worldwide. The yearly mortality rate is over 5.5 million (1). However, in Pakistan, the estimated annual incidence of stroke is 250/100,000 or 350,000 cases; with the bulk occurring in the middle-aged. Due to a lack of information about the illness and its treatment choices, hundreds of individuals die each year, and an even more significant number live with a lifelong disability (2).

If determined to be ischemic, stroke is treated immediately with an intravenous injection of recombinant tissue plasminogen activator, r-tPA, which is the standard gold treatment, according to guidelines, as long as the patients are transferred to a stroke unit within 4.5 hours. Thrombectomy, stents, surgery, and other medicines are also used (1).

---Continue

Published

2022-12-15

Issue

Section

Letter to the Editor